Skip to content

Clinical trials

Completed Lung Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Status: Completed Clear all

705 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200013
200118
200218
200314
200416
200517
200616
20079
20089
200931
201024
201115
201222
201327
201422
201523
201629
201733
201826
201938
202038
202132
202224
202331
202418
20257
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed705

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)112
AstraZeneca33
Novartis Pharmaceuticals13
NYU Langone Health10
University of Pittsburgh8
Brigham and Women's Hospital7
Riphah International University7
University of California, San Francisco7
Columbia University6
Johns Hopkins University6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases705
Pulmonary Disease, Chronic Obstructive126
Asthma120
Respiratory Tract Diseases94
Lung Diseases, Obstructive52
Cystic Fibrosis42
Lung Neoplasms42
Heart Diseases38
Cardiovascular Diseases34
Neoplasms33

Trials

Showing 76 to 100 of 705. Each trial links to its page on Pharma Observatory.

605 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.